Detected ·
Dash Bio
$30M—
Dash Bio raised $30M in a Series A led by Oak HC/FT. The company uses custom robotics and proprietary software to transform bioanalysis for drug discovery, reducing turnaround times from months to days with upfront pricing and sample-level transparency. In less than a year since launch, Dash has signed 30+ customers including four of the world's top 25 pharma companies.
- Website
- dash.bio
- linkedin.com/company/dashbio
- Amount
- $30 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-04 04:03:24 UTC
- Signal ID
- 1471f7d3-7d81-4c5a-b99c-d44b9c85ee35
As the API returns it
{
"id": "1471f7d3-7d81-4c5a-b99c-d44b9c85ee35",
"created_at": "2026-08-04T04:03:24.130353Z",
"company_name": "Dash Bio",
"company_website_url": "dash.bio",
"company_linkedin_url": "https://www.linkedin.com/company/dashbio",
"event_type": "funding",
"funding_amount": 30000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Dash Bio raised $30M in a Series A led by Oak HC/FT. The company uses custom robotics and proprietary software to transform bioanalysis for drug discovery, reducing turnaround times from months to days with upfront pricing and sample-level transparency. In less than a year since launch, Dash has signed 30+ customers including four of the world's top 25 pharma companies.*"
}